(Q41875243)

13 October 2017

0 references

Severe acute hepatitis B treated with entecavir (English)

1 reference

13 October 2017

Giuseppe Vittorio Luigi De Socio

1

1 reference

13 October 2017

Alessio Sgrelli

2

1 reference

13 October 2017

Andrea Tosti

3

1 reference

13 October 2017

Franco Baldelli

4

1 reference

13 October 2017

15 March 2011

1 reference

Mediterranean journal of hematology and infectious diseases

13 October 2017

1 reference

13 October 2017

3

1 reference

13 October 2017

1

1 reference

13 October 2017

e2011010

1 reference

Chronic hepatitis B: update 2009

13 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3103261

EASL Clinical Practice Guidelines: management of chronic hepatitis B.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3103261

Clinical aspects of hepatitis B virus infection

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3103261

The study of efficacy of lamivudine in patients with severe acute hepatitis B.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3103261

Hepatitis B-associated acute liver failure: immediate treatment with entecavir inhibits hepatitis B virus replication and potentially its sequelae

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3103261

Entecavir to treat severe acute hepatitis B.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3103261

Efficacy and safety of entecavir in patients with chronic hepatitis B and advanced hepatic fibrosis or cirrhosis

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3103261

Acute hepatitis B: is antiviral therapy indicated? Two case reports

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3103261

Lamivudine treatment for acute severe hepatitis B: a pilot study

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3103261

[Features of clinical evolution of severe acute viral hepatitis. Series of 72 cases]

18 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21625314

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Quantitative analysis of HBsAg, IgM anti-HBc and anti-HBc avidity in acute and chronic hepatitis B

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21625314

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A randomized controlled trial of lamivudine to treat acute hepatitis B

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21625314

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.4084/MJHID.2011.010

1 reference

13 October 2017

0 references

1 reference

13 October 2017

1 reference